Literature DB >> 10709113

Hormone-dependent nuclear localization of the tyrosine kinase iyk in the normal human breast epithelium and loss of expression during carcinogenesis.

G Berclaz1, H J Altermatt, V Rohrbach, E Dreher, A Ziemiecki, A C Andres.   

Abstract

iyk, a member of the frk family of non-receptor tyrosine kinases, was originally isolated from normal mouse mammary glands and is characterized by a nuclear localizing signal within the SH2 domain. We have investigated the expression and subcellular localization of iyk in the normal human breast and in malignant breast diseases. Immuno-histochemical analyses revealed that in normal tissue iyk localizes to both cytoplasmic and nuclear compartments of breast epithelial cells. The subcellular distribution was dependent on the hormonal state, being mostly cytoplasmic during the follicular, proliferative phase of the menstrual cycle, whereas frequent nuclear staining was observed in the resting stages during the luteal phase and, most prominently, after menopause. Strikingly, invasive carcinomas, irrespective of tumor type or hormonal status of the patient, exhibited almost complete loss of iyk expression in both the cytoplasm and the nucleus. In contrast, in situ breast carcinomas from post-menopausal patients showed a clear reduction of the nuclear iyk localization while retaining cytoplasmic staining. Our results indicate that iyk expression is gradually lost during carcinogenesis; thus, iyk may be classified as a tumor-suppressor gene. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10709113     DOI: 10.1002/(sici)1097-0215(20000315)85:6<889::aid-ijc25>3.0.co;2-4

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  FRK suppresses the proliferation of human glioma cells by inhibiting cyclin D1 nuclear accumulation.

Authors:  Lei Hua; Ming Zhu; Xu Song; Jun Wang; Zhen Fang; Chunting Zhang; Qiong Shi; Wenjian Zhan; Lei Wang; Qingming Meng; Xiuping Zhou; Rutong Yu
Journal:  J Neurooncol       Date:  2014-05-03       Impact factor: 4.130

Review 2.  RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Cell Cycle       Date:  2009-09-29       Impact factor: 4.534

3.  Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation.

Authors:  Edward T Bagu; Sayem Miah; Chenlu Dai; Travis Spriggs; Yetunde Ogunbolude; Erika Beaton; Michelle Sanders; Raghuveera K Goel; Keith Bonham; Kiven E Lukong
Journal:  Oncotarget       Date:  2017-02-14

4.  FRK inhibits breast cancer cell migration and invasion by suppressing epithelial-mesenchymal transition.

Authors:  Yetunde Ogunbolude; Chenlu Dai; Edward T Bagu; Raghuveera Kumar Goel; Sayem Miah; Joshua MacAusland-Berg; Chi Ying Ng; Rajni Chibbar; Scott Napper; Leda Raptis; Frederick Vizeacoumar; Franco Vizeacoumar; Keith Bonham; Kiven Erique Lukong
Journal:  Oncotarget       Date:  2017-12-06

5.  The role of Rak in the regulation of stability and function of BRCA1.

Authors:  Jung-Lye Kim; Geun-Hyoung Ha; Loredana Campo; Mitchell F Denning; Tarun B Patel; Clodia Osipo; Shiaw-Yih Lin; Eun-Kyoung Breuer
Journal:  Oncotarget       Date:  2015-10-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.